Cargando…
Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
BACKGROUND: Hydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure prophylaxis it may prevent COVID-19. OBJECTIVE: To compare the incidence of COVID-19 in Spanish patients with autoimmune rheumatic disea...
Autores principales: | Macías, Juan, González-Moreno, Paz, Sánchez-García, Esther, Morillo-Verdugo, Ramón, Pérez-Venegas, José J., Pinilla, Ana, Macho, MªMar, Martínez, MªVictoria, González-Serna, Alejandro, Corma, Anaïs, Real, Luis M., Pineda, Juan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031374/ https://www.ncbi.nlm.nih.gov/pubmed/33831011 http://dx.doi.org/10.1371/journal.pone.0249036 |
Ejemplares similares
-
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020) -
Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
por: Santos, Marta, et al.
Publicado: (2023) -
Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022) -
Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023) -
Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)